$4.17 -0.01 (-0.239%) Arena Pharmaceuticals Inc - NASDAQ

Nov. 21, 2014 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
9/17/2014LIEF JACKChairman, President and CEO100,000$1.4929.32%
7/01/2014LIEF JACKChairman, President and CEO-223,525$5.85-38.24%
6/27/2014BELCHER DONALD DDirector-2,473$5.85-2.56%
6/27/2014BELCHER DONALD DDirector2,473$5.462.63%
5/12/2014SPECTOR STEVEN WEVP, General Counsel & Sec-45,000$7.05-30.57%
5/12/2014SPECTOR STEVEN WEVP, General Counsel & Sec45,000$1.4944.04%
5/06/2014BELCHER DONALD DDirector4,176$4.316.08%
5/06/2014BELCHER DONALD DDirector-4,176$7.00-5.73%
4/22/2014HIXSON HARRY F JRDirector25,000$4.1130.17%
4/22/2014HIXSON HARRY F JRDirector11,900$4.1111.03%
4/22/2014HIXSON HARRY F JRDirector-36,900$6.31-30.81%
4/01/2014SHANAHAN WILLIAM R JRSVP & Chief Medical Officer60,000$6.30171.43%
4/01/2014SHANAHAN WILLIAM R JRSVP & Chief Medical Officer-60,000$6.37-63.16%
4/01/2014BELCHER DONALD DDirector1,905$6.302.77%
4/01/2014BELCHER DONALD DDirector-1,905$6.45-2.70%
3/04/2014SPECTOR STEVEN WEVP, General Counsel & Sec-100$7.01-0.10%
3/04/2014SPECTOR STEVEN WEVP, General Counsel & Sec-24,900$7.01-19.64%
3/04/2014SPECTOR STEVEN WEVP, General Counsel & Sec25,000$1.4924.56%
1/17/2014LIEF JACKChairman, President and CEO100,000$6.0017.13%
1/17/2014LIEF JACKChairman, President and CEO-100,000$7.81-14.63%
1/10/2014BEHAN DOMINIC PEVP & Chief Scientific Officer-33,332$6.25-6.46%
1/10/2014BEHAN DOMINIC PEVP & Chief Scientific Officer33,332$6.006.90%
1/09/2014BICE SCOTT HDirector25,000$6.00105.81%
1/09/2014BICE SCOTT HDirector-25,000$6.10-51.41%
1/09/2014BELCHER DONALD DDirector5,000$6.005.33%
1/09/2014BELCHER DONALD DDirector-30,000$6.15-30.39%
1/09/2014SPECTOR STEVEN WEVP, General Counsel & Sec33,334$6.0032.75%
1/09/2014SPECTOR STEVEN WEVP, General Counsel & Sec-33,334$6.10-24.67%
11/12/2013SPECTOR STEVEN WEVP, General Counsel & Sec-20,000$5.19-21.88%
11/12/2013SPECTOR STEVEN WEVP, General Counsel & Sec20,000$1.4928.00%
9/10/2013BEHAN DOMINIC PEVP & Chief Scientific Officer-200,000$6.31-30.63%
9/10/2013BEHAN DOMINIC PEVP & Chief Scientific Officer50,000$1.818.29%
9/10/2013BEHAN DOMINIC PEVP & Chief Scientific Officer150,000$1.4933.11%
9/05/2013SPECTOR STEVEN WEVP, General Counsel & Sec-20,000$6.54-21.97%
9/05/2013SPECTOR STEVEN WEVP, General Counsel & Sec20,000$1.4928.15%
5/21/2013Audet Craig MichaelSVP, Opn & Head Glob Reg Afrs-83,750$8.00-84.81%
5/21/2013Audet Craig MichaelSVP, Opn & Head Glob Reg Afrs46,250$1.8188.10%
5/21/2013Audet Craig MichaelSVP, Opn & Head Glob Reg Afrs37,500$1.28250.00%
4/01/2013HOFFMAN ROBERTSVP, Finance and CFO-71,250$8.21-78.45%
4/01/2013HOFFMAN ROBERTSVP, Finance and CFO71,250$1.81364.08%
10/01/2012HOFFMAN ROBERTSVP, Finance and CFO-50,000$8.32-93.66%
10/01/2012HOFFMAN ROBERTSVP, Finance and CFO50,000$1.481,478.42%
7/05/2012HOFFMAN ROBERTSVP, Finance and CFO-10,000$11.00-78.35%
7/03/2012SPECTOR STEVEN WEVP, General Counsel & Sec22,300$4.0156.33%
7/03/2012SPECTOR STEVEN WEVP, General Counsel & Sec-22,300$10.05-36.03%
7/02/2012SPECTOR STEVEN WEVP, General Counsel & Sec-39,365$10.04-49.86%
7/02/2012SPECTOR STEVEN WEVP, General Counsel & Sec-95,000$9.96-54.61%
7/02/2012SPECTOR STEVEN WEVP, General Counsel & Sec45,000$1.4934.90%
7/02/2012SPECTOR STEVEN WEVP, General Counsel & Sec30,000$3.2530.32%
7/02/2012SPECTOR STEVEN WEVP, General Counsel & Sec22,699$4.0129.77%
7/02/2012SPECTOR STEVEN WEVP, General Counsel & Sec16,666$6.0027.97%
3/29/2012Bielasz Jennifer KathleenSr.Dir. of Acct. & Cont. (PAO)-4,550$3.01-48.66%
3/29/2012Bielasz Jennifer KathleenSr.Dir. of Acct. & Cont. (PAO)-6,250$3.04-40.06%
3/29/2012Bielasz Jennifer KathleenSr.Dir. of Acct. & Cont. (PAO)6,250$1.4966.84%
1/06/2012HOFFMAN ROBERTVP, Finance and CFO-150$1.63-1.22%
1/06/2012HOFFMAN ROBERTVP, Finance and CFO150$1.641.24%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ARNA), click here.
Trading Center